Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-10 receptor 1 is a cell surface receptor that serves as the primary binding site for the anti-inflammatory cytokine interleukin-10 (IL-10)[1][3][4]. Structurally, it is a transmembrane glycoprotein composed of extracellular, transmembrane, and intracellular domains, and belongs to the class II cytokine receptor family[1][3]. Signal transduction occurs upon assembly of a heterodimeric receptor complex including IL-10R1 and the accessory protein IL-10R2 (IL-10RB); binding of IL-10 to IL-10R1 initiates intracellular signaling cascades—primarily JAK1/TYK2 kinases which phosphorylate STAT3—leading to suppression of inflammatory responses and promotion of regulatory and anti-apoptotic pathways[1][3][4]. The receptor is widely expressed on hematopoietic and immune cells, and its activity is essential for limiting the extent and duration of immune and inflammatory
Activation of Janus kinase 1 (JAK1) and Tyrosine kinase 2 (TYK2) following ligand binding leads to phosphorylation of STAT transcription factors, predominantly STAT3, driving anti-inflammatory gene expression and inhibition of pro-inflammatory cytokine signaling[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-10 receptor 1 (IL-10R1).